Energy » Fossil Fuels | Changsheng Biotechnology Co. Ltd.

Changsheng Biotechnology Co. Ltd. A | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
369
260
2,259
2,365
2,314
Total Accounts Receivable
49
508
492
666
861
Inventories
210
209
274
254
227
Other Current Assets
3
32
27
80
29
Total Current Assets
631
1,009
3,053
3,366
3,432
Net Property, Plant & Equipment
124
396
447
490
642
Total Investments and Advances
-
57
100
-
130
Intangible Assets
20
58
52
120
224
Other Assets
-
-
-
12
5
Total Assets
776
1,559
3,695
4,038
4,510
ST Debt & Current Portion LT Debt
-
150
50
47
66
Accounts Payable
40
96
89
63
49
Income Tax Payable
-
61
16
33
45
Other Current Liabilities
22
207
217
282
402
Total Current Liabilities
62
514
372
426
561
Long-Term Debt
-
-
-
6
6
Provision for Risks & Charges
-
-
1
-
-
Deferred Taxes
1
31
36
43
69
Other Liabilities
4
-
-
-
-
Total Liabilities
66
528
386
433
569
Common Equity (Total)
706
1,006
3,286
3,565
3,857
Total Shareholders' Equity
706
1,006
3,286
3,565
3,857
Total Equity
706
1,007
3,287
3,583
3,876
Liabilities & Shareholders' Equity
776
1,559
3,695
4,038
4,510
Accumulated Minority Interest
-
1
1
18
19
Non-Equity Reserves
3
24
22
22
65

About Changsheng Biotechnology Co.

View Profile
Address
No. 1615 Yueda Road
Changchun Jilin 130103
China
Employees -
Website -
Updated 07/08/2019
Changsheng Bio-technology Co., Ltd. engages in the manufacture, research and development, and sale of human vaccines. Its products include vaccine for DTC combines, rabies F and V, varicella, influenza, and hepatitis A. The company was founded on August 18, 1992 and is headquartered in Changchun, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.